← Back to headlines
FDA Grants Clearance for Roche and Eli Lilly Alzheimer’s Blood Tests
Regulatory approval marks a significant milestone in early dementia detection, enabling widespread clinical use of blood-based biomarkers for Alzheimer’s disease diagnosis.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


